From October 1, 2022 to December 31, 2022, the company has repurchased 729,189 shares, representing 0.79% for CNY 50.54 million. With this, the company has completed the repurchase of 2,518,674 shares, representing 2.74% for CNY 150.01 million under the buyback announced on September 6, 2022.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.72 CNY | +0.58% | -5.32% | -27.60% |
29/04 | Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
1st Jan change | Capi. | |
---|---|---|
-27.60% | 367M | |
-5.43% | 182B | |
+4.30% | 114B | |
-3.09% | 68.38B | |
+5.86% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.